Safety and Feasibility of ActivSightTM in Human

Inclusion Criteria: * All patients age \>= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age \>= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent. * Diagnosis: * All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection. * All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy. * Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis. * Any bariatric patients undergoing gastric sleeve or bypass. * Any pediatric patient undergoing laparotomy for necrotizing enterocolitis * Location of pathology or resected segment: * Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses. * Prior therapy: * Patients with prior surgery are eligible for enrollment. * Laboratory: * Hemoglobin \> 9 g/dL * Platelet count ≥75,000/μL (may receive transfusions) * Normal prothrombin time, tested prothrombin, and international normalized ratio \< 1.5 x upper limit of normal (ULN) (including patients on prophylactic ant…